ARNT2 is downregulated and serves as a potential tumor suppressor gene in non-small cell lung cancer

[1]  P. He,et al.  TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor , 2014, Tumor Biology.

[2]  Daniel J. Peet,et al.  bHLH–PAS proteins in cancer , 2013, Nature Reviews Cancer.

[3]  D De Ruysscher,et al.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  L. Qin,et al.  Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma , 2012, International journal of cancer.

[5]  H. Sone,et al.  siRNA‐mediated knockdown of aryl hydrocarbon receptor nuclear translocator 2 affects hypoxia‐inducible factor‐1 regulatory signaling and metabolism in human breast cancer cells , 2011, FEBS letters.

[6]  J. Osinga,et al.  Variants in RET associated with Hirschsprung's disease affect binding of transcription factors and gene expression. , 2011, Gastroenterology.

[7]  S Senan,et al.  Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  O. Hankinson,et al.  The aryl hydrocarbon receptor nuclear translocator (Arnt) is required for tumor initiation by benzo[a]pyrene. , 2009, Carcinogenesis.

[9]  L. O’Driscoll,et al.  Drug metabolism-related genes as potential biomarkers: analysis of expression in normal and tumour breast tissue , 2008, Breast Cancer Research and Treatment.

[10]  O. Hankinson.  Why does ARNT2 behave differently from ARNT? , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  R. Pollenz,et al.  Analysis of Ah receptor-ARNT and Ah receptor-ARNT2 complexes in vitro and in cell culture. , 2008, Toxicological sciences : an official journal of the Society of Toxicology.

[12]  Y. Fujii‐Kuriyama,et al.  Unique and Overlapping Transcriptional Roles of Arylhydrocarbon Receptor Nuclear Translocator (Arnt) and Arnt2 in Xenobiotic and Hypoxic Responses* , 2006, Journal of Biological Chemistry.

[13]  M. Pelto-huikko,et al.  Expression of Arnt and Arnt2 mRNA in Developing Murine Tissues , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[14]  Madeleine Moussa,et al.  Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  Y. Fujii‐Kuriyama,et al.  cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon receptor nuclear translocator (Arnt) , 1996, Molecular and cellular biology.

[16]  O. Hankinson,et al.  Identification of the Ah Receptor Nuclear Translocator Protein (Arnt) as a Component of the DNA Binding Form of the Ah Receptor , 1992, Science.

[17]  C. Gridelli,et al.  Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  A. Jemal,et al.  Global Cancer Statistics , 2011 .